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Background: Biomarkers of peripheral muscle fatigue (BPMFs) are used to offer insights into mechanisms of
exhaustion during exercise in order to detect abnormal fatigue or to detect defective metabolic pathways. This
review aims at describing recent advances and future perspectives concerning the most important biomarkers of
muscle fatigue during exercise.
Results: BPMFs are classified according to the mechanism of fatigue related to adenosine-triphosphate-metabolism,
acidosis, or oxidative-metabolism. Muscle fatigue is also related to an immunological response. impaired calcium
handling, disturbances in bioenergetic pathways, and genetic responses. The immunological and genetic response
may make the muscle susceptible to fatigue but may not directly cause muscle fatigue. Production of BPMFs is
predominantly dependent on the type of exercise. BPMFs need to change as a function of the process being
monitored, be stable without appreciable diurnal variations, correlate well with exercise intensity, and be present in
detectable amounts in easily accessible biological fluids. The most well-known BPMFs are serum lactate and
interleukin-6. The most widely applied clinical application is screening for defective oxidative metabolism in
mitochondrial disorders by means of the lactate stress test. The clinical relevance of most other BPMFs, however, is
under debate, since they often depend on age, gender, physical fitness, the energy supply during exercise, the type
of exercise needed to produce the BPMF, and whether healthy or diseased subjects are investigated.
Conclusions: Though the role of BPMFs during fatigue is poorly understood, measuring BPMFs under specific,
standardised conditions appears to be helpful for assessing biological states or processes during exercise and
fatigue.
Keywords: Biomarker, Biological marker, Muscle fatigue, Monitoring, Muscle exercise, Exercise fatigueReview
Introduction
Fatigue in response to exercise (exercise (-induced)
fatigue) can be caused by mental disorders, organic
central nervous system (CNS) abnormalities (central
fatigue), or by peripheral nervous system (PNS) dysfunction
or skeletal muscle disease (peripheral, muscle, contractile,
or mechanical fatigue, contractile impairment, loss of
force generating capacity) [1,2]. Factors that contribute to
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Chronic fatigue syndrome (CFS)
Exercise-induced muscle fatigue has to be clearly deli-
neated from fatigability in the resting stage (fatigue prior
to exercise), which may be caused by similar or other
factors than exercise-induced muscle fatigue. Exercise-
induced muscle fatigue is defined as a reversible loss of
muscle force (muscle contractility) during work over time
(peripheral muscle fatigue during exercise) [4,5]. Clinically
useful biomarkers are available to quantify the degree and
course of muscle fatigue during exercise and disease. This
review is directed towards researchers and clinicians and
aims to describe recent advances and future perspectives
concerning the most important biomarkers of muscle fa-
tigue during exercise.
Exercise
Voluntary muscle exercise can be carried out in an incre-
mental or constant manner (endurance), or in a dynamic
(cycling, running) or static mode. Exercise can also be ex-
haustive or non-exhaustive. Exhaustive exercise includes
acute, very prolonged exercise, a period of intensified
training, non-functional overreaching and the overtraining
syndrome. Exercise can be carried out under aerobic or
anaerobic conditions. Examples of partially anaerobic ex-
ercise include sprinting, where maximal efforts last <1 mi-
nute, and exercise under high-force isometric conditions.
Only a very few types of exercise are entirely anaerobic,
and these necessarily last for only a few seconds. Contrac-
tions during exercise may be isometric or non-isometric,
isokinetic (constant velocity throughout movement) or
non-isokinetic (changing velocity during contraction), or
concentric (muscle shortening) or eccentric (muscle leng-
thening). All of these different conditions are not exclu-
sive, i.e. a cycling exercise may be constant, dynamic,
non-isometric and concentric.
Exercise-induced muscle fatigue, fatigability, tiredness,
and recovery
Muscle fatigue is defined as decreased ability to generate
appropriate amounts of muscle force or power during
on-going contractile activity. Muscle fatigue may vary
according to the cause or underlying mechanisms, with
variable rates of recovery. For example, fatigue brought on
by a marathon is different from fatigue that prevents a
10th bench press repetition at a given resistance. Exercise-
induced muscle fatigue can occur shortly after onset of
exercise (acute muscle fatigue) or after a constant, high-
intensity exercise had been carried out for a prolonged
period of time (delayed exercise-induced fatigue), which is
characterized by tiredness only after a longer duration ofconstant exercise. Acute muscle fatigue is usually maximal
immediately post-exercise. Exercise-induced muscle fa-
tigue can develop under a sub-maximal as well as maxi-
mal intensity exercise. Exercise-induced fatigue can occur
in healthy or diseased subjects, and depends on age, gen-
der, physical fitness, mode and duration of exercise, and
the underlying disease.
Contrary to fatigue, the term fatigability is defined as
rate of loss of muscle force over time. Fatigability is an
interactive determinant of the state of fatigue versus
rested. Only few studies have addressed the relation bet-
ween fatigability and biomarkers of muscle fatigue. Mus-
cle fatigue has to be delineated from the sensation of
tiredness. Muscle fatigue that develops during submaxi-
mal aerobic exercise is not necessarily reflected by a sen-
sation of tiredness, but a reduced ability to develop force
and power. Recovery from fatigue is defined as the rate
at which muscle function returns to baseline after be-
coming fatigued. Recovery represents an important
marker of fatigue severity and biomarker responsive-
ness. Like fatigability, recovery represents an interactive
determinant of the state of fatigue versus rested. Both,
fatigue severity and recovery are influenced by fatiga-
bility and the degree to which muscle dysfunction is
provoked.
Fatigue versus muscle damage
Decrease in force production during exercise can be
regarded as a safety mechanism. If fatigue would not
occur or was delayed, structural damage to muscle cells
and supportive tissues would occur during the workout.
Skeletal muscle is generally composed of slow-twitch and
fast-twitch muscle fibres [6]. Slow-twitch fibres are also
referred to as type-I, whereas fast-twitch fibres are referred
to as type-IIa, typeIIx, or type-IIb [6]. The differentiation
is based on histochemical staining for myosin adenosine-
triphosphatase (ATPase) and the type of myosin heavy
chain [6]. Slow-twitch fibres are better equipped to work
aerobically, whereas fast-twitch fibres are better equipped
to work anaerobically. Particularly in type-II fibres, CK-
activity serves as a temporal or spatial buffer of the
adenosine-triphosphate (ATP) content [7]. Both type-I
and type-II fibres produce interleukin (IL)-6 [8]. Muscle
fatigue, which can be recovered from fairly quickly, must
be clearly distinguished from muscle damage, which usu-
ally takes a longer recovery period. Since muscle fatigue
is not accompanied by structural damage to myofibrils
and muscle damage can occur without exercise inducing
it (e.g. contusion, excessive stretching, rhabdomyolysis),
biomarkers for both of these conditions must be differen-
tiated. There are, however, conditions under which bio-
markers of muscle fatigue coexist with biomarkers of
muscle damage (e.g. inflammatory biomarkers). In par-
ticular, high-intensity eccentric contractions can result in
Table 1 Criteria for the classification of biomarkers of
muscle fatigue
Criterion Mode of exercise
Type of exercise Aerobic/anaerobic





Investigated compartment Fluids (serum, saliva, urine), cells
(blood, muscle)
Type of individual Human being, animal
Delay of production Early production/delayed production
Metabolic state Anabolic/catabolic
Biochemical reaction Acidosis, immunologic, oxidative,
hormonal








Thiobarbituric acid reactive substances
(TBARS)
Serum





Glutathione peroxidase (GTX) Serum, leukocytes
Catalase Serum
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the biomarker is indicative of fatigue or muscle damage.
Biomarkers
A biomarker (biological marker) is a measurable product
or substance of an organism that is used as an indicator
of a biological state to objectively measure physiological
or pathogenic processes in the body that occur during
health, disease or in response to pharmacological treat-
ment [9]. In medicine, a biomarker can also represent a
substance that is introduced into an organism to exami-
ne organ functions or other aspects of health (e.g. single
photon emission-computed tomography tracers, which
are used as radioactive isotopes to assess the number
of dopamine-producing cells). A biomarker can also be
a substance that indicates a particular disease state
(e.g. acetylcholine receptor antibodies indicate myasthenia
gravis). More specifically, a biomarker indicates a change
in the expression or state of a protein that correla-
tes with the risk or progression of a disease, or with
the susceptibility of the disease to a given treatment
(e.g. tumour markers). Criteria a biomarker needs to meet
are that it changes as a function of the process being mon-
itored, can be accurately measured; is stable and does not
show diurnal variations, correlates with exercise intensity,
and is present in detectable amounts in easily accessible
biological fluids [10]. Biomarkers of muscle fatigue should
be selected such that they do not overlap with biomarkers
of muscle damage.
Biomarkers of peripheral muscle fatigue
Biomarkers can be categorized according to the type
of exercise or workload carried out (short or long
term, aerobic exercise or anaerobic exercise, or both(e.g. lymphocytes increase during aerobic exercise))
[11] or according to the delay before which they are
detectable after onset or discontinuation of exercise
(Table 1) [12].
The concentration of a biomarker produced depends
on the amount of fatigue that is induced and on the type
and duration of the exercise. A further classification re-
lies on the biochemical pathway from which the bio-
marker originates (Table 2).
However, the most plausible classification of biomar-
kers of muscle fatigue follows the mechanisms of fatigue
and the metabolic changes during fatigue. Since there is
no single cause of muscle fatigue, there is also no single
biomarker for assessing muscle fatigue. Studies of several
biomarkers during muscle strength decline showed that
multiple elevated catabolic biomarkers are a better pre-
dictor of muscle fatigue than a single biomarker [12].
Biomarkers of muscle fatigue are different for exercise
that lasts 20s in duration, which have an anaerobic en-
ergy demand of up to 90%, compared to exercise that
lasts 20s to 1 minute, which is maintained by both an
anaerobic and aerobic energy supply, and compared to
exercise that lasts > 1 minute, for which the energy sup-
ply is > 50% aerobic. Biomarkers of muscle fatigue from
low- and high-intensity exercise are thus different and
their return to normal values depends on the rate of re-
covery of muscle performance. If fatigue is still present
but the biomarker is back to pre-exercise values, then
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way to assess fatigue resistance is to compare the maxi-
mal force a muscle (group) can generate after contractile
activity with the force/power the muscle could generate
before onset of the contractile activity [13].
Biomarkers classified according to muscle fatigue
mechanism
Initially, it was believed that acidosis is the major cause
of muscle fatigue [14]. Meanwhile, however, it turned
out that there is no single mechanism but multiple
mechanisms of fatigue, of which the most important in-
clude: 1. acidosis and depletion of ATP due to increased
consumption or decreased provision, reflected by the
biomarkers serum lactate, ammonia, and oxipurines, and
2. overproduction of reactive oxygen species (ROS), re-
flected by lipid peroxidation biomarkers, protein peroxida-
tion biomarkers, and antioxidantive capacity biomarkers.
Less well-defined causes of muscle fatigue include local in-
flammatory reactions reflected by the biomarkers leuko-
cytes, tumour necrosis factor (TNF)-α, and ILs, altered
Ca2+ release and handling [2], disturbed bioenergetic
pathways (e.g. glycogen depletion), or the impaired endo-
crine function of muscle cells. Muscle fatigue is also
reflected by an increase in the activity of genes involved in
any of these mechanisms. Local inflammatory reactions to
exertion during workload, which continue during the
hours after exercise, may not only reflect muscle fatigue
but also damage that occurred during exercise.
ATP metabolism
To which degree shortage in ATP contributes to muscle
fatigue is under debate. Though decrease of muscle ATP
can be observed during repetitive or prolonged muscle
contraction, there are indications that decrease in high
energy compounds (e.g. ATP, phospho-creatine (PCr))
are not enough to result in even a small level of muscle
dysfunction [15]. There are even observations, indicating
that ATP may remain constant with decreasing force
[16]. However, there are also indications that decrease
of ATP at specific locations or in association with the
function of transport systems may contribute to the de-
velopment of muscle fatigue. An argument against ATP-
depletion as a fatigue mechanism is that the muscle is
surprisingly tolerant to an increase in ADP and to a de-
crease in energy from ATP [17]. Generally, ATP is
synthesized by four processes: the conversion of PCr at
onset of exercise, anaerobic glycolysis during intensive
short-term muscle work, the conversion of two ADP
molecules to ATP and AMP during heavy exercise, and
aerobic glycolysis under most exercise conditions [18].
At the beginning of exercise the total adenine nucleotide
pool (ATP + ADP + adenosine-monophosphate (AMP))
remains constant, since ADP is reconverted to ATP inorder to maintain the delivery of energy for exercise [18].
With increasing duration and intensity of exercise, the
ATP:adenosine-diphosphate (ADP) ratio decreases due to
excessive ATP consumption (Gibb’s free energy of ATP
hydrolysis declines) and the total adenine nucleotide pool
decreases due to AMP deamination. Progressive accu-
mulation of AMP deamination products, which include
inosin-monophosphate (IMP) and ammonia [18], causes
fatigue but there is only a trivial correlation between fa-
tigue and IMP concentration. Patients with AMP dea-
minase deficiency are more susceptible to fatigue than
controls, suggesting that this enzyme plays a key role in
fatigue resistance [18]. Fatigue can also result from a lack
of PCr and an accumulation of intracellular phosphorus
with decreasing force [19]. Since the resynthesis of PCr
and the removal of phosphorous are both oxygen de-
pendent, there might be a link between aerobic fitness and
fatigue during work [19].
A key role for muscle fatigue plays intracellular aci-
dosis. Even minimal decrease in muscle pH interferes
with cross-bridge binding and ATPase activity due to
competitive binding and reduced enzyme function. Cross
bridge detachment is unaffected by fatigue whereas cross
bridge attachment is reduced during fatigue [16]. De-
creased intracellular pH may additionally impair oxida-
tive enzyme activity and may adversely affect ryanodine
receptor function [20]. Although some studies showed a
relation between exercise and biomarkers of ATP-meta-
bolism, there are still concerns on how to assess fatigue by
measuring them. The most well-known biomarkers of
muscle fatigue deriving from ATP metabolism include
serum lactate, serum ammonia and the oxipurines hypo-
xanthine and xanthine.
Lactate In cases, in which the oxidative phosphorylation
of ADP to generate ATP fails to meet the energy re-
quirement of the myocyte, which is the case under acidic
conditions, the production of ATP shifts from aerobic
processes (the processing of glucose/glycogen, lipids or
amino acids) to anaerobic glycolysis or glycogenolysis
(the processing of glucose/glycogen) [4]. Whether the
change to anaerobic glycolysis results in lactate produc-
tion only in case of inadequate oxygen supply to allow
the transport of pyruvate to mitochondria, is under de-
bate. Generally, elevated serum lactate reflects that the
aerobic ATP generation is insufficient for the required
ATP generation and needs to be supplemented with an-
aerobic ATP generation. The percentage of the maximal
workload during increasing exercise at which lactate sur-
mounts above normal levels is called the lactate thres-
hold. World-class athletes have a lactate threshold of
70-90% compared to 50-60% in untrained individuals.
Lactate production is enhanced when the level of high-
energy phosphates other than ATP (e.g. PCr) is reduced,
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spectroscopy [4]. Lactic acidosis also results from liver
dysfunction since lactate is transferred into glucose via
the Cori cycle in the liver. If lactate clearance via the
Cori cycle no longer keeps up with lactate production,
lactic acidosis is the consequence. Meanwhile, however,
there are also indications that the muscle not only plays
an important role in lactate production but also in lac-
tate clearance [21].
Reference limits for serum lactate are reported as >
2 mmol/l [22]. Serum lactate does not increase with age,
does not differ between the genders, and does not seem
to depend on the physical fitness of the proband but
increases with the intensity of exercise in healthy and
diseased subjects and in trained and untrained indivi-
duals when exercise exceeds the lactate threshold [23].
With incremental exercise, serum lactate increases expo-
nentially above a certain work-rate. When fatigue was
compared between male adolescents and adults, post-
exercise serum lactate increased more in adults as com-
pared to adolescents [24]. In prolonged constant-load
endurance exercise, lactate typically increased by < 5
mmol/l. Lactate also increased during and after exercise
in animals [25]. Generally, lactate increases at lower rela-
tive workloads in patients as compared to healthy sub-
jects. Lactate increases at low workloads particularly in
patients with impaired oxidative phosphorylation (mito-
chondrial disorders) and patients with pulmonary di-
sease. In patients with COPD, serum lactate was found
to increase up to the maximal capacity during a stepwise
exercise test on an ergocycle [26]. Lactic acidosis can re-
sult in hypocalcaemia and hypomagnesaemia [23]. Des-
pite these influences on serum lactate levels, lactate
appears to be a promising biomarker of muscle fatigue if
workload conditions are standardised [4].
Ammonia If the consumption of ATP exceeds the ATP
supply, the ATP:ADP ratio decreases and impairs the
functioning of the major ATPases in myocytes, including
myosin ATPase (70%), endoplasmatic reticulum Ca-
ATPase (25%), and sarcolemmal Na/K-ATPase [4]. Im-
pairment of myocyte ATPases leads to fatigue [4]. In
order to maintain the ATP: ADP ratio, the enzyme
adenylate-kinase transfers one energy-rich phosphate
group from one ADP to another ADP, resulting in one
ATP and one AMP. AMP is subsequently degraded by
the enzyme AMP-deaminase to IMP and ammonia [27].
AMP acts by activating the AMP-kinase (AMPK), which
is the key sensor of cellular energy stress [28]. The
AMPK in myocytes is activated by exercise and is par-
tially responsible for the acute metabolic response of the
muscle to exercise [29]. It also improves the substrate
supply for metabolic pathways producing ATP, and in-
hibits anabolic processes to spare ATP [28]. AMPK isparticularly involved in the switch from the anaerobic me-
tabolism of glycogen to the oxidative metabolism of blood
glucose and fatty acids [29]. AMPK is also responsible for
long-term metabolic adaptations, such as the increase in
number of mitochondria to aerobic exercise in endurance
training [29]. Ammonia is usually determined in the serum.
Reference limits of ammonia have been repeatedly
reported but depend on a number of variables. Serum
ammonia does not seem to be age-dependent [30]. De-
pendency on sex, and physical fitness was not exten-
sively investigated, but increase of ammonia after sprint
exercise was higher in men as compared to females [31].
In trained and untrained healthy subjects performing a
maximal ergocycle exercise, ammonia increased by 32%
during exercise. Because AMP degradation is enhanced
during exercise, serum ammonia and intracellular IMP
levels concomitantly increase [4,32]. Since ammonia
closely follows the lactate response during exercise [4], it
lends itself to monitoring muscle fatigue.
Hypoxanthine and xanthine (oxipurines) Hypoxan-
thine is a naturally occurring purine derivative, which
occasionally is a constituent of nucleic acids, where it is
present in the anticodon of tRNAs in the form of in-
osine. Hypoxanthine and xanthine are derived from the
degradation of purinic nucleotides (adenine, guanine) [33].
Hypoxanthine is produced by the action of xanthine oxi-
dase on xanthine. More frequently, however, hypoxan-
thine is formed by xanthine oxidoreductase from the
reduction of xanthine. Hypoxanthine-guanine phospho-
ribosyltransferase converts hypoxanthine into IMP in
nucleotide salvage. IMP is degraded to inosine and hypo-
xanthine by a 5’-nucleotidase [33]. Hypoxanthine and
xanthine are usually analysed in the serum or urine.
Reference limits for hypoxanthine were reported to range
between 0 and 8 μmol/l [34]. Influences on the variability
of these biomarkers are largely unknown. Age-dependency
of serum hypoxanthine is not well investigated but diffe-
rences between the genders seem to exist [35]. No reliable
data about the dependency of hypoxanthine on the physical
fitness are available. During and after prolonged isokinetic
exercise to exhaustion, performed by healthy males in a
concentric mode, serum hypoxanthine and xanthine levels
were found to significantly increase immediately after exer-
cise depending on the amount of joint excursion [33], ren-
dering hypoxanthine useful for monitoring the metabolic
stress of muscle tissue during training or rehabilitation pro-
grams [33]. Since serum hypoxanthine is directly correlated
with the amount of ATP consumed inside the cell [33], it is
a good biomarker of muscle fatigue [36].
Oxidative stress biomarkers
One of the most promising groups of biomarkers of
muscle fatigue is that related to oxidative stress, which is
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radicals) [37]. ROS have an electron in excess, which
not only cause fatigue but also mitochondrial damage.
Increased ROS production during exercise results in the
oxidation of proteins, lipids or nucleic acids [38]. The pro-
duction of ROS during fatigue is also accompanied by a
marked reduction in the antioxidant capacity, which is par-
tially proportional to the training load [10]. ROS are capable
of activating the transcription factors known to regulate
IL-6 [9]. The production of ROS during exercise is occa-
sionally accompanied by inflammation or soreness, and
increases in a biphasic manner [39]. Though influence of
ROS on muscle fatigue is complex and elevation of a mar-
ker after exercise does not necessarily indicate that it is a
key determinant of fatigue, measuring oxidative damage
biomarkers, such as lipid peroxidation biomarkers, (thiobar-
bituric acid-reactive substances (TBARS), Isoprostanes)
protein oxidation biomarkers (protein carbonyls) or bio-
markers of antioxidant capacity, (glutathione (GSH), gluta-
thione peroxidase (GPX), catalase, total antioxidant
capacity (TAC)) appears to be promising to assess fatigue.
Thiobarbituric acid-reactive substances (TBARS)
Thiobarbituric acid-reactive substances (TBARS) are
low-molecular weight end products formed during the
decomposition of lipid peroxidation products that react
with thiobarbituric acid to form a fluorescent red
adduct. TBARS occur in the serum most likely due to
peroxidation of low-density lipoproteins and oxygen-
mediated injury of myocyte membranes [40]. TBARS are
indicators of lipid peroxidation and oxidative stress [41].
TBARS are usually determined in the serum but are also
detectable in the saliva [42].
Reference limits for serum TBARS at baseline were
reported as 6.8-8.0 μM [10] but are influenced by a
number of variables. TBARS increased with age in ery-
throcytes [43] and were reported to be lower in females
compared to males [44]. TBARS increased with increas-
ing physical fitness [10]. Serum concentration of TBARS
increased immediately after exercise and again after a
delay of several hours. Although exercise-induced oxida-
tive stress is highest immediately after exercise, lipid
peroxidation can take place even some time after exer-
cise [45]. In healthy subjects, TBARS increased 5 min
after an incremental cycling exercise and during static
exercise [23,46]. In healthy males undergoing seven
multi-joint resistance exercises six times a week with 1-6
repetitions at 85-100% of maximal strength (overtraining),
a >48-h delayed increase of TBARS by 56% compared to
baseline was observed [10]. This increase was triggered by
leukocyte and macrophage infiltration or xanthine oxidase
activation and attributed to the ischaemic reperfusion
process. In healthy males a period of intensified training
elicited an increase of lipid peroxidation in 96% of thecases, but only after high-volume and very-high-volume
training [10]. In patients with CFS, there was a linear cor-
relation between resting fatigue, as assessed by a visual
analogue scale, and TBARS [41]. A linear correlation was
also found between fatigue and the lag phase, defined as
the time necessary to initiate peroxidation, which precedes
the formation of conjugated dienes [41]. In CFS patients
undergoing incremental exercise to exhaustion, a post-
exercise increase in TBARS and a decrease in reduced
ascorbic acid were observed [47]. The increase in TBARS
was accompanied by delayed but markedly reduced heat
shock protein (HSP) 27 and HSP70 levels [47] suggesting
that prolonged and accentuated oxidative stress during
exercise might result from delayed or insufficient HSP
production [47].
Isoprostanes Isoprostanes are prostaglandin-like com-
pounds that, in vivo, derive from peroxidation of essen-
tial fatty acids (mainly arachnoidic acid) catalysed by
ROS and without the action of cyclo-oxygenase. Isopros-
tanes are esterified to phospholipids in cell membranes
and are released in the free form to circulate in body
fluids by the action of phospholipases [10]. Isoprostanes
are accurate markers of lipid peroxidation and their
exercise-associated increase reflects the oxidative dam-
age to cell membranes following muscle activity [10].
Isoprostanes can also act as direct inflammatory media-
tors and augment the perception of pain. Isoprostanes
are usually determined in the serum, urine, or other
body fluids and blood cells.
Reference limits of isoprostanes in the serum were
reported as 1.5-1.8 ng/ml [10] but depend on a number
of influences. Isoprostanes increase with age [48] and
have been reported to be slightly lower in females com-
pared to men [49]. Isoprostanes increase with physical
fitness [10]. In healthy males, isoprostanes increased 2.4-
fold in the urine after low volume training, 4-fold after
high-volume training, and 7-fold after very-high-volume
training [10]. The increase in isoprostanes was corre-
lated with a decrease in performance and an increase in
training volume [10]. In a study of ultra-marathon run-
ners, peripheral F2-isoprostane increased by 57% [50].
Protein carbonyls Protein carbonyls are mainly derived
from the oxidation of albumin or other serum proteins
[51]. Protein carbonyls are regarded as a marker of oxi-
dative protein injury [52]. Accumulation of protein car-
bonyls over time is an indicator of oxidative damage to
proteins during ageing [53]. Protein carbonyls are usu-
ally determined in the serum. Reference limits of protein
carbonyls were reported as 0.30-0.36 nmol/mg [10] but
vary with a number of conditions [54]. Protein carbonyls
increased with age in one study [53] and decreased with
age in another [55]. Protein carbonyls were higher in
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and increased with physical fitness [10]. In healthy
males, protein carbonyls increased by 50% under intense,
high-volume training and by 73% under very-high-
volume training [10]. Protein carbonyls remained ele-
vated 96 h post-exercise. In healthy cross-trained men
undergoing continuous cycling at 70% of VO2max for
30 min and intermittent dumbbell squatting, protein
carbonyls increased 1.6-2.4-fold 24 h post-exercise [38].
After ultra-marathon running, elevated protein carbo-
nyls reached the maximum level 48 h post-competition
[56]. The post-exercise rise in protein carbonyls is attrib-
uted to phagocytic cell invasion into the muscle, which
generates ROS and is accompanied by inflammation and
soreness [57]. In overtrained athletes protein carbonyls
increased already before exercise.
Glutathione (GSH) Glutathione (GSH) is a pseudo-
tripeptide that is present in nearly all cells at high
concentrations. Glutathione is one of the most important
antioxidants and an important reserve of cysteine. GSH
is also important for the phase-II biotransformation of
toxic substances. For this purpose, halogen-, sulphate-,
sulphonate-, phosphate- or nitrate groups are substituted
by GSH. In addition to ROS scavenging, GSH is required
for the regeneration of ascorbic acid and α-tocopherol
[58]. GSH is not only present in cells but is detectable also
in the serum and saliva [42].
Reference limits of GSH in the serum were reported
as 0.36-0.41 mM but depend on a number of conditions
[10]. GSH levels were lower in males compared to
females and decreased with age [59] and with increasing
physical fitness [10]. GSH in erythrocytes decreased by
31% after high-volume training in healthy trained males
[10]. Simultaneously, oxidized glutathione (GSSG)
increased by 25% and the GSH: GSSG ratio, another
valid oxidative stress marker, decreased by 56% [10]. The
decrease in the GSH: GSSG ratio was highly correlated
with a drop in performance and a training volume
increase, suggesting that the supply of GSH is not suffi-
cient to match its enhanced utilization during overtrain-
ing or that the clearance of GSH from the blood is
increased [10]. A decrease in GSH was also observed
during static exercise [37]. Under continuous cycling
at 70% of VO2max for 30 min and intermittent dumbbell
squatting, GSH decreased by 21% whereas GSSG
increased by 25% [38]. In healthy non-smokers the con-
sumption of GSH was maximal 5 min after an incre-
mental cycling exercise [37].
Glutathione peroxidase (GPX) Glutathione peroxidase
(GPX) is an enzyme that scavenges hydrogen peroxide
(H2O2) at low levels of exercise, while at higher training
volumes the production of H2O2 exceeds the capabilitiesof GPX. To compensate for the insufficient clearance of
H2O2 by GPX, the production of catalase is increased at
higher levels of exercise [10]. H2O2 is formed by dismu-
tation of superoxide (O2-), which is formed by xanthine-
oxidase during the degradation of IMP to uric acid [60].
Excess of H2O2 causes loss of muscle contractility and
thus augments muscle fatigue [60]. GPX occurs ubiqui-
tously and can be found in most body fluids and cells.
Reference limits of GPX in peripheral blood mono-
nuclear cells were reported as 509.3 ± 26.3 U/g protein in
16 healthy controls [61] but reference values depend on
various factors. GPX activity in erythrocytes decreased
with age [62]. GPX was sex-dependent and higher in
females under chronic stress as compared to males [63].
GPX-activity in erythrocytes was also dependent on the
physical fitness since it increased in sedentary females per-
forming Tai Chi during 8 weeks [64]. In healthy subjects,
GPX increased with the intensity of exercise [10,65]. GPX
decreased by 50% in neutrophils and increased by 87% in
lymphocytes [66]. In this study GPX increased already
below peak oxidative stress levels.
Catalase Catalase is an ubiquitously occurring enzyme
that catalyses the decomposition of H2O2 to water and
oxygen. The enzyme has one of the highest turnover
rates, converting millions of H2O2 molecules per
single catalase molecule each second. The enzyme is a
tetramer with polypeptide chains that are more than
500 amino acids long. Catalase is usually determined
in the serum [10].
Reference limits of catalase are reported to range from
96.8 to 129.8 MU/1 in 1756 healthy individuals but de-
pend on various influences [67]. In this study catalase
values were lower in females and decreased with age
[67]. On the contrary, no gender difference was reported
in healthy sport students [68]. In the latter study, cata-
lase increased after short-distance running [68]. Catalase
levels do not seem to be dependent on the physical fit-
ness of the probands [69]. In healthy males, serum cata-
lase levels increased only after very-high-volume training
[10]. A positive correlation between catalase levels and
training volume was also reported in other studies [65].
In professional cyclists, the catalase levels in neutrophils
decreased by 40% 3 h post-competition [66].
Total antioxidant capacity (TAC) TAC is defined as
the sum of antioxidant activities of the nonspecific pool
of antioxidants, consisting of antioxidant enzymes (GPX,
catalase, superoxide dismutase), metal chelators, and
nonspecific antioxidants (GSH, ascorbic acid, albumin,
uric acid, tocopheroles, carotenoids, coenzyme-Q, biliru-
bin, and amino acids (cystein, methionine, tyrosine)).
The non-enzymatic antioxidant properties of the TAC
are usually measured by means of the ferric reducing
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measured in the serum [10].
Among 13 healthy subjects, aged 18-22y, TAC ranged
between 1.26 and 1.89 mmol/l [71]. TAC seems to in-
crease with age since protein carbonyls and advanced
oxidation protein products (AOPPs) increased with age
and were correlated with TAC [72]. In a Chinese cohort,
TAC levels were higher in males as compared to females
[73]. No data about the dependency of TAC on the
physical fitness were available. In a cohort of sedentary
healthy males, TAC decreased after treadmill exercise
[71]. In healthy males a period of intensified training eli-
cited a biphasic TAC response, a significant increase
after low- and high-volume training, and a decline after
very-high-volume training [10]. After all training stages
uric acid increased and accounted for about one third of
the TAC increase [10]. Additionally, GSH contributed to
the increase in TAC [10]. Uric acid and urea also
increased immediately after a soccer game in female
players and returned to baseline no earlier than 21 h
later [51]. The increase in TAC suggests that the body’s
antioxidant defense system is activated during exercise
[74]. Mobilization of antioxidant tissue stores may help
to maintain the antioxidant status if needed [75]. When
measuring the non-enzymatic antioxidant properties
after exercise, TAC decreased in healthy controls taking
a placebo and in patients being treated with a cysteine
donor [70]. In patients with a mitochondrial disorder,
TAC decreased after a series of 3 minute incremental
exercises (60-70 revolutions/min) [70]. In this study,
work was increased from 25 W to 70% of the predicted
maximal power output or until the highest workload
that could be maintained [70].
Inflammatory biomarkers
In addition to ATP-depletion and ROS production, exer-
cise and fatigue trigger an inflammatory reaction. After
exercise, T-lymphocytes are mobilized into the blood.
Available data indicate that contracting skeletal muscle
releases myokines (cytokines produced from muscle) to
create a systemic anti-inflammatory environment against
this inflammatory reaction and to exert specific endo-
crine effects on visceral fat [8]. This anti-inflammatory
reaction has recently been described by Brandt and
Pedersen as the myokine concept, which regards the
skeletal muscle as an endocrine organ [8]. The concept
relies on the fact that muscle fibres produce, express,
and release cytokines and other peptides that exert para-
crine or endocrine effects [8]. If these endocrine or para-
crine functions are not regularly stimulated by muscle
contractions, dysfunction of the muscle (muscular endo-
crine dysfunction) and other organs and tissues may fol-
low, resulting in cardiovascular disease, malignancy or
dementia [8]. Myokines produced by the skeletal muscleinclude IL-6, IL-8, IL-15, brain-derived neurotrophic
factor, leukaemia inhibitory factor, fibroblast growth fac-
tor 21 and follistatin-like-1 [8]. Myofibrils also release
mechano-growth factors, which impart autocrine effects
on the muscle fibre. Relevant inflammatory biomarkers
are catabolic biomarkers [18] and include cells involved
in the cellular immune response, pro-inflammatory
cytokines, such as ILs, IL-receptor antagonists (IL-RA),
TNF-α [76] and other markers of inflammation [18].
Leukocytes Aerobic physical activity elicits the mobi-
lization of T-lymphocytes into the blood from periphe-
ral lymphoid compartments immediately after exercise,
which is quickly followed by lymphocytopenia during the
recovery phase [77]. This effect is most pronounced for
cluster of differentiation (CD) 8 and natural killer cell popu-
lations [77]. Recruitment of T-lymphocytes from the
marginal pool represents a nonspecific immune response
that occurs in the presence of ischemia of a stressed tissue
but in the absence of a real injury [33]. Since immune cells
generate ROS, the simultaneous promotion of post-exercise
inflammation, tissue removal and healing occur [10].
Reference limits of T-lymphocytes depend on age, sex,
and the method applied [78]. T-cells expressing CD8 were
reported to be lower in old as compared to young healthy
subjects [79] but other studies showed T-lymphocyte
subpopulations to increase with age [78]. Sex differences
in the T-cell immune responses are particularly evident
in diseased subjects [80]. In healthy subjects of any age,
CD4+ and CD8+ lymphocytes are mobilized into the
peripheral blood compartment after exercise [77]. Also,
CD3+, CD4+, CD8 bright and CD56+ lymphocytes were
found to increase immediately after an intensive treadmill
running protocol in aerobically trained male runners [8].
In this study, the percentage of CD3 + -T-lymphocytes
expressing killer cell lectin-like receptor subfamily G1
(KLRG1) and CD57 increased with exercise. After 1 h of
recovery, mobilized T-lymphocytes expressing KLRG1
and CD57 disappeared from the peripheral blood com-
partment [8]. An increase in CCR5+, CCR5+/CD8 and
CCR5+/CD45RO-T-cell subpopulations was also reported
in frail patients [81]. These changes indicate that T-cells
mobilized by exercise have an advanced stage of biological
aging and a reduced capacity for clonal expansion com-
pared to T-cells resident in the blood [8]. In addition to
lymphocytes, also neutrophils showed a significant in-
crease immediately after exercise in healthy males during
prolonged, isokinetic exercise, performed in a concentric
mode at different joint excursions [33].
Interleukin-6 Interleukin-6 (IL-6) belongs to a group of
cytokines that regulate the body’s inflammatory reaction.
IL-6 acts as both a pro-inflammatory (monocytes, macro-
phages) and anti-inflammatory (myocytes) cytokine [8,82].
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stimulate the immune response to trauma or other tissue
damage, leading to inflammation. IL-6 cleaves the recep-
tor-subunit glycoprotein gp130. Additionally, IL-6 func-
tions as a myokine, which increases in response to muscle
contractions [8,9,83]. Serum IL-6 exponentially increases
with exercise duration up to 100-fold, is rapidly released
into circulation, precedes the appearance of other cy-
tokines, peaks immediately post-exercise, and returns to
resting levels within a few hours of recovery [83,84]. The
exponential increase is related to exercise duration, inten-
sity, the muscles engaged in mechanical work and endu-
rance capacity [83]. During exercise, IL-6 is thought to
act in a hormone-like manner to mobilize extracellu-
lar substrates or augment substrate delivery [85]. IL-6 is
markedly produced during the post-exercise period when
insulin action is enhanced, but IL-6 is also associated with
obesity and reduced insulin action [8]. IL-6 increases glu-
cose uptake, hepatic glucose production during exercise,
insulin-mediated glucose disposal, lipolysis and fat oxida-
tion via activation of AMPK or PI3-kinase [8,9]. IL-6 is
secreted by osteoblasts to stimulate osteoclast formation
and by smooth muscle cells in the tunica media of blood
vessels as a pro-inflammatory cytokine. Its role as an anti-
inflammatory cytokine is mediated through its inhibitory
effects on TNF-α and IL-1, and the activation of IL-1RA
and IL-10 [8,83]. IL-6 is usually determined in the serum
and probably the most frequently studied cytokine.
Among 54 healthy controls, reference limits of IL-6
ranged between 1.0 and 4.8 pg/ml but were sex-related
[86]. IL-6 serum levels were independent of age but were
reported lower in females as compared to controls [79].
IL-6 levels are typically increased in inflammatory and
immunological disease [86]. In a study of sedentary sub-
jects and athletes, IL-6 levels increased with isometric
force and mechanical fatigue [87]. IL-6 also increased in
highly trained endurance athletes in response to four
weeks of intense running [88]. However, IL-6 did not in-
crease during incremental exercise to exhaustion in
patients with CFS [47]. The increase of IL-6 during exer-
cise may be blunted by the ingestion of carbon-rich food
[84] but not by fat. In a study of 716 community-
dwelling subjects the decrease in maximal isometric
hand-grip strength over 6 years was predicted by high
IL-6 and IL-1RA levels [12]. IL-6 can also be determined
in the saliva [87], but no significant relationship was
found between serum and salivary IL-6 levels under rest-
ing or post-exercise conditions [87]. When recombinant
IL-6 is actively administered, it impairs the performance
of long-distance runners and increases the sensation of
fatigue in trained runners [84]. Fatigue resistance was
also found to be worse in patients with high levels of IL-
6 compared to patients with high IL-6 but low HSP70
levels [89].TNF-α TNF-α is a pro-inflammatory cytokine that is
predominantly produced by macrophages and able to in-
duce apoptosis, inflammation, cell proliferation and cell
differentiation, and to inhibit tumourgenesis and viral
replication. TNF-α is part of the cytokine system, which
modulates the organo-neogenesis. TNF-α indirectly cau-
ses insulin resistance by increasing the release of free
fatty acids from fat tissue and increasing lipolysis in adi-
pocytes [8]. Dysregulation of TNF-α is implicated in the
development of cancer, can induce fiver and contributes
to the development of cachexia. It also mediates limb
muscle contractile dysfunction through the TNF-receptor
type 1. TNF-α can be determined in the serum and va-
rious cells.
Reference limits of TNF-α under resting conditions
ranged between 0.78 and 3.12 pg/ml [71] and seem to be
independent of age, sex, and physical condition. Expres-
sion of TNF-α mRNA in fibroblasts increased with age
[90] but TNF-α serum levels were not different between
young and old controls [79]. Sex differences of TNF-α
have not been reported in a study of 28 controls [79].
TNF-α levels did not change with increased physical
fitness [71]. In patients with sarcoidosis undergoing a
maximal incremental cycling exercise test, muscle
fatigue was associated with increased serum levels of
TNF-α [3]. In a study of 716 community-dwelling
subjects, the decrease in maximal isometric hand-grip
strength over several years was associated with increas-
ing TNF-α level [12].
Genetic response biomarkers (mRNA upregulation)
Exercise results in the upregulation of several genes, as
can be demonstrated by increases in mRNA for these
genes. For example, the transcriptional rate of the IL-6
gene is markedly enhanced and IL-6 mRNA upregulated
during muscle contraction [83]. In resting muscle, the
IL-6 gene is silent but is rapidly activated by contraction
[83]. Like IL-6, IL-8 mRNA was increased after a 3 h
treadmill run and after a 1 h cycle ergometer exercise
without a concomitant increase in serum IL-8 levels [9].
In 19 patients with CFS, who were studied during a
25 min cycling exercise to determine the amount of
mRNA of metabolite-detecting genes (ASIC3, P2X4,
P2X5), adrenergic genes (A2A, B-1, B-2, COMT) and
immune system genes (IL-6, IL-10, TNF-α, TLR4,
CD14), the activity of the genes encoding for ASIC3,
P2X4, P2X5, B-1, B-2, COMT, IL-10, TLR4 and CD14
increased significantly in blood lymphocytes 30 min,
24 h and 48 h post-exercise [91]. The gene activity per-
sistently increased between 0.5-48 h after exercise [91],
suggesting that dysregulation of metabolite-detecting
receptors occurs during fatigue [76,92]. In a study of
subjects exposed to exhaustive exercise, both serum IL-6
and muscle IL-6 mRNA increased [93]. Furthermore,
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expression of selected genes, which interact with mito-
chondrial apoptosis and biogenesis.
Potential biomarkers of muscle fatigue
Potential BPMFs due to oxidative stress include H2O2,
vitamin E, and the nonspecific antioxidants albumin and
ascorbic acid. In patients with CFS, vitamin E levels in
the serum significantly decreased with increasing fatigue
[10]. Five minutes after an incremental cycling exercise,
the maximal consumption of plasma ascorbic acid and a
slight decrease in the total antioxidant capacity were
reported [37]. Further potential biomarkers of fatigue
due to oxidative stress could be HSP27 and HSP70,
which protect cells against oxidative stress but decreased
after an incremental cycling test in CFS patients. AOPP
represent another potential biomarker of oxidative me-
tabolism during muscle fatigue. AOPP derive from the
peroxidation of proteins such as oxidized albumin [94].
AOPP have no oxidant properties and correlate with dity-
rosin and the advanced glycation end product pentosidine,
which both represent other indices of oxidant-mediated
protein damage. Other potential immunological biomar-
kers include C-reactive protein, high-sensitivity C-reactive
protein, IL-1RA, IL-8, IL-10, IL-15, TNF-αR1, and plasma
DNA [8,18,95].
Parameters unsuitable as biomarkers
A number of biomarkers turned out unsuitable as a bio-
marker for muscle fatigue during exercise.
Parameters that failed to serve as biomarkers of
muscle fatigue so far include elastase, IL-1beta and com-
plement C4a [8,95]. The concentration of these markers
did not change substantially after sub-maximal exercise or
self-paced limited exercise in CFS patients and controls
[96]. Another parameter that does not seem to be a pre-
dictor of a decrease in muscle strength is the insulin-like
growth factor [18]. In a study of muscle fatigue in patients
with sarcoidosis, this parameter did not increase in the
patient group [3]. Although brain-derived neurotrophic
factor mRNA and protein expression are increased in ske-
letal muscle after exercise, the muscle-derived and brain-
derived neurotrophic factor are not released into the
circulation [8].
Accuracy of biomarkers
Although biomarkers appear to be a valuable tool for
measuring and monitoring muscle fatigue, it is still under
debate, which ones are reliable and the most relevant for
clinical use. Among the many biomarkers reported here,
the most accurate and valid biomarkers of muscle fatigue
are serum lactate and IL-6, but ammonia, oxipurines, the
lymphocyte counts or oxidative stress parameters were
also investigated for their impact on muscle fatigue. Thebest biomarkers for monitoring high-intensity muscle
fatigue include lactate, IL-6, TBARS, oxipurines and inor-
ganic phosphate [95]. Biomarkers which best reflect low-
intensity fatigue include lactate, leukocytes and TBARS.
Recovery from muscle fatigue and the resumption of nor-
mal function is best monitored by serum lactate, the
leukocyte count and IL-6. An example of the clinical ap-
plication of lactate determination during muscle fatigue is
the lactate stress test. This test is carried out during a
constant or incremental workload and indicates disturbed
oxidative metabolism. There is, however, no general agree-
ment on the sensitivity or specificity of the lactate stress
test. Some authors regard it as being highly useful [96],
whereas others consider this test inappropriate [97]. In a
study of 291 patients with mitochondrial disorders, the
sensitivity/specificity of the lactate stress test was 66/84%,
respectively [96]. In a study of 15 patients, however, the
sensitivity/specificity of the lactate stress test was only 27/
86%, respectively [97], but in this study the workload was
incremental and not constant.Conclusions
Biomarkers are reliable tools for measuring and moni-
toring muscle fatigue, but the parameters that are the
most applicable for this purpose are still being debated.
Reasons for the unsatisfactory situation are that validity
and reliability, but also proven effectiveness in assessing
muscle fatigue, are strongly dependent on the wide
range of settings (at rest in the clinic, before during or
after exercise in the laboratory) and on the range of
population groups (elite athletes, moderately active indi-
viduals, sedentary individuals). Other reasons are the still
poorly understood physiological changes that skeletal
muscle undergoes during fatigue and the huge number
of candidates for biomarkers of muscle fatigue, which
have either been barely investigated or do not fulfill the
criteria of a biomarker. Furthermore, the causal relation-
ship between the biomarkers described and fatigue still
needs to be proven, although some correlate substan-
tially with the loss of muscle function. Different assay
methods for the discussed biomarkers may also have an
impact on their reliability. So far, the most frequently
investigated and most widely applied biomarkers of mus-
cle fatigue are serum lactate and IL-6. Additionally, am-
monia, leukocytes and oxidative stress parameters are
gaining increasing attention. Biomarkers of muscle fa-
tigue could be a prognostic tool for identifying subjects
at increased risk of strength decline, but it is unknown
whether the interventional lowering of biomarkers can
prevent or alleviate muscle strength loss during exercise.Competing interests
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